Virtus Fund Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Virtus Fund Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$398K	Buy	+9,447	New	+$364K	﹤0.01%	354

Other funds holding MYOK

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Virtus Fund Advisers's MYOK Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in MyoKardia, Inc. Common Stock (MYOK) in Q4 2017: 9,447 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #354 among its holdings.

121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

Virtus Fund Advisers held 9,447 shares of MyoKardia, Inc. Common Stock worth $398K as of Q4 2017.
MyoKardia, Inc. Common Stock was a new Virtus Fund Advisers position in Q4 2017.
MyoKardia, Inc. Common Stock made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #354 holding.
121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.